About GLPG
GLPG is a company based in Mechelen (Belgium) founded in 1999.. GLPG has raised $26.1 million across 21 funding rounds from investors including Gilead, Apax Partners and Crucell. The company has 704 employees as of December 31, 2024. GLPG has completed 3 acquisitions, including Abound Bio, CellPoint and Inpharmatica. GLPG offers products and services including Cell Therapy Platform and Small Molecules. GLPG operates in a competitive market with competitors including BeiGene, Biogen, Moderna, UCB and Incyte, among others.
- Headquarter Mechelen, Belgium
- Employees 704 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Galapagos Nv
-
Annual Revenue
$286.37 M (USD)14.99as on Dec 31, 2024
-
Net Profit
$76.96 M (USD)-65.01as on Dec 31, 2024
-
EBITDA
$-190.76 M (USD)-99.8as on Dec 31, 2024
-
Total Equity Funding
$26.1 M (USD)
in 21 rounds
-
Latest Funding Round
$410.58 M (USD), Post-IPO
Nov 01, 2019
-
Investors
Gilead
& 10 more
-
Employee Count
704
as on Dec 31, 2024
-
Investments & Acquisitions
Abound Bio
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of GLPG
GLPG is a publicly listed company on the EURONEXT with ticker symbol GLPG in Netherlands, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of GLPG
GLPG offers a comprehensive portfolio of products and services, including Cell Therapy Platform and Small Molecules. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops scalable cell therapies for oncology and hematological needs.
Assets targeting auto-immune diseases through clinical trials.
Unlock access to complete
Unlock access to complete
Funding Insights of GLPG
GLPG has successfully raised a total of $26.1M across 21 strategic funding rounds. The most recent funding activity was a Post-IPO round of $410.58 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 21
- Last Round Post-IPO — $410.6M
- First Round First Round
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2019 | Amount | Post-IPO - GLPG | Valuation |
investors |
|
| Jun, 2019 | Amount | Post-IPO - GLPG | Valuation |
investors |
|
| Jan, 2018 | Amount | Grant - GLPG | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GLPG
GLPG has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Gilead, Apax Partners and Crucell. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity investments are focused on tech, services, and consumer sectors.
|
Founded Year | Domain | Location | |
|
Early stage venture capital firm investing in US
|
Founded Year | Domain | Location | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GLPG
GLPG has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Abound Bio, CellPoint and Inpharmatica. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of discover, development, and manufacturing services for cancer and infectious disease
|
2019 | ||||
|
CAR-T cell therapeutics are provided for hematological malignancies.
|
2018 | ||||
|
Developer of predictive informatics based platform for drug discovery
|
1998 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - GLPG
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glpg Comparisons
Competitors of GLPG
GLPG operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Biogen, Moderna, UCB and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for immunological and neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Plasma-derived therapies are developed to treat multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Glpg
Frequently Asked Questions about GLPG
When was GLPG founded?
GLPG was founded in 1999.
Where is GLPG located?
GLPG is headquartered in Mechelen, Belgium. It is registered at Mechelen, Antwerp, Belgium.
Is GLPG a funded company?
GLPG is a funded company, having raised a total of $26.1M across 21 funding rounds to date. The company's 1st funding round was a Grant of $32.43K, raised on Jun 01, 1999.
How many employees does GLPG have?
As of Dec 31, 2024, the latest employee count at GLPG is 704.
What is the annual revenue of GLPG?
Annual revenue of GLPG is $286.37M as on Dec 31, 2024.
What does GLPG do?
Founded in 1999 and headquartered in Mechelen, Belgium, small molecule drugs and antibody programs are discovered and developed by the company. Focus is placed on immunology, oncology, cystic fibrosis, inflammation, and other indications within the biotechnology sector. Operations involve advancing therapeutic candidates through research and clinical stages for various diseases.
Who are the top competitors of GLPG?
GLPG's top competitors include Moderna, BeiGene and Strand Therapeutics.
What products or services does GLPG offer?
GLPG offers Cell Therapy Platform and Small Molecules.
Is GLPG publicly traded?
Yes, GLPG is publicly traded on EURONEXT under the ticker symbol GLPG.
How many acquisitions has GLPG made?
GLPG has made 3 acquisitions, including Abound Bio, CellPoint, and Inpharmatica.
Who are GLPG's investors?
GLPG has 11 investors. Key investors include Gilead, Apax Partners, Crucell, Gimv, and European Union.
What is GLPG's ticker symbol?
The ticker symbol of GLPG is GLPG on EURONEXT.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.